Evidence map›Paper›PMID 25211869›Full record

ReviewMissouri medicine

Intratympanic steroid therapy for treatment of idiopathic sudden sensorineural hearing loss.

Zachary W Bear, Anthony A Mikulec

Open access · greenAbstract readReview
In one paragraph

Review in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Efficacy ofComputational and mathematical methods in medicine · 2022
    Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Intratympanic Dexamethasone in Sudden Sensorineural Hearing Loss.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2022
    Article
  9. Coronavirus disease 2019 and sudden sensorineural hearing loss.The Journal of laryngology and otology · 2020
    Article
  10. Inner ear delivery: Challenges and opportunities.Laryngoscope investigative otolaryngology · 2020
    Review
  11. Inner Ear Therapeutics: An Overview of Middle Ear Delivery.Frontiers in cellular neuroscience · 2019
    Review
  12. Acquired sensorineural hearing loss in children: current research and therapeutic perspectives.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2017
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zachary W Bear
Anthony A Mikulec

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic sudden sensorineural hearing loss (ISSHL) is the sudden loss of unilateral hearing of unknown etiology. The standard treatment consist of a high dose oral steroid taper. This article serves to review the current literature on intratympanic steroid injections for ISSHL. Current literature suggested intratympanic steroids are equivalent to oral steroid therapy, primary combined therapy is superior to either alone and intratympanic steroids should be offered for salvage therapy in ISSHL.

Indexed as

GlucocorticoidsHearing Loss, SensorineuralHearing Loss, SuddenHumansInjectionsTympanic MembraneGlucocorticoids

Identifiers

PMID25211869
PMCPMC6179477
OpenAlexW2403716037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.